Solitary breast mass as initial presentation of clinically silent metastatic renal cell carcinoma

Breast

Volumn 15, Issue 3, 2006, Pages 426-428

  McLauglin, Sarah A ^a   Thiel, David D ^a   Smith, Stephen L ^a   Wehle, Michael J ^a   Menke, David M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast; Carcinoma; Extramammary breast metastases; Recurrent carcinoma; Renal cell

Indexed keywords

INTERLEUKIN 2; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BREAST METASTASIS; BREAST TUMOR; CANCER IMMUNOTHERAPY; CANCER PATIENT; CASE REPORT; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; NEPHRECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT CANCER; TUMOR VOLUME; ECHOGRAPHY; ECHOMAMMOGRAPHY; IMMUNOTHERAPY; KIDNEY TUMOR; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; TUMOR RECURRENCE;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; ULTRASONOGRAPHY, MAMMARY;

EID: 33744550483     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.09.009     Document Type: Article

References (5)

1. Pagano S., Francoso F., and Ruggeri P. Renal cell carcinoma metastases. Review of unusual clinical metastases, metastatic modes and patterns and comparison between clinical and autopsy metastatic series. Scand Urol Nephrol 30 (1996) 165-172
2. Vassalli L., Ferrari V.D., Simoncini E., et al. Solitary breast metastases from a renal cell carcinoma. Breast Cancer Res Treat 68 (2001) 29-31
3. Vergier B., Trojani M., de Mascarel I., et al. Metastases to the breast: differential diagnosis from primary breast carcinoma. J Surg Oncol 48 (1991) 112-116
4. Chhieng D.C., Cohen J.M., Waisman J., et al. Fine-needle aspiration cytology of renal-cell adenocarcinoma metastatic to the breast: a report of three cases. Diagn. Cytopathol 21 (1999) 324-327
5. Eklund J.W., and Kuzel T.M. A review of recent findings involving interleukin-2-based cancer therapy. Curr Opin Oncol 16 6 (2004) 542-546